Todd Young serves as an executive vice president and chief financial officer (CFO) at Elanco Animal Health Incorporated. In this role, he is responsible for leading all of the company’s financial operations.
Young brings significant financial leadership experience in pharmaceutical and healthcare, as well as a focus on strategic and commercial decision-making to his position. Prior to joining Elanco, Young served as the chief financial officer at ACADIA Pharmaceuticals Inc, where he oversaw the company’s financial functions, including accounting and financial planning and analysis. He also had responsibility for the information technology and facility groups. Young has also served as senior vice president and treasurer at Baxalta, a bio-pharmaceutical leader in hematology, immunology and oncology that was created as a tax-free spin-off from Baxter International. He has also served as corporate vice president and treasurer of Baxter. At Baxter, Young also served in roles including vice president of international finance, vice president of global financial planning and analysis, vice president of finance of Asia Pacific, and assistant treasurer. He started at Baxter in the tax group.
Young received his bachelor’s degree in economics from Grinnell College and a Juris Doctor from the University of Michigan.
Sign up to view 10 direct reports
Get started